[HTML][HTML] PSMA ligands for radionuclide imaging and therapy of prostate cancer: clinical status

S Lütje, S Heskamp, AS Cornelissen, TD Poeppel… - Theranostics, 2015 - ncbi.nlm.nih.gov
Prostate cancer (PCa) is the most common malignancy in men worldwide, leading to substantial
morbidity and mortality. At present, imaging of PCa has become increasingly important …

[HTML][HTML] Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma

S Lütje, JWJ de Rooy, S Croockewit, E Koedam… - Annals of …, 2009 - Springer
Multiple myeloma is a malignant B-cell neoplasm that involves the skeleton in approximately
80% of the patients. With an average age of 60 years and a 5-years survival of nearly 45% …

Dual-modality image-guided surgery of prostate cancer with a radiolabeled fluorescent anti-PSMA monoclonal antibody

S Lütje, M Rijpkema, GM Franssen… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Both radionuclide imaging and near-infrared fluorescent (NIRF) imaging have a high
sensitivity to detect tumors in vivo. The combination of these modalities using dual-labeled …

[HTML][HTML] Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19

S Lütje, M Marinova, D Kütting… - Nuklearmedizin …, 2020 - thieme-connect.com
The current outbreak of coronavirus SARS-CoV-2 has reached multiple countries worldwide.
While the number of newly diagnosed cases and fatalities is rising quickly, far-reaching …

Imaging of prostate-specific membrane antigen expression in metastatic differentiated thyroid cancer using 68Ga-HBED-CC-PSMA PET/CT

S Lütje, B Gomez, J Cohnen, L Umutlu… - Clinical nuclear …, 2017 - journals.lww.com
Purpose The prostate-specific membrane antigen (PSMA) was shown to be overexpressed
on the neovasculature of several malignancies. Here, the role of 68 Ga-HBED-CC-PSMA PET…

[HTML][HTML] PSMA-targeting agents for radio-and fluorescence-guided prostate cancer surgery

…, M Gotthardt, OC Boerman, M Rijpkema, S Lütje… - Theranostics, 2019 - ncbi.nlm.nih.gov
Despite recent improvements in imaging and therapy, prostate cancer (PCa) still causes
substantial morbidity and mortality. In surgical treatment, incomplete resection of PCa and …

[HTML][HTML] 68Ga-PSMA-HBED-CC PET/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a phase 2 imaging study

W van Boxtel, S Lütje, ICH van Engen-van Grunsven… - Theranostics, 2020 - ncbi.nlm.nih.gov
Rationale: Treatment options for recurrent and/or metastatic (R/M) adenoid cystic carcinoma
(ACC) and salivary duct carcinoma (SDC), major subtypes of salivary gland cancer, are …

[HTML][HTML] Machine learning facilitates hotspot classification in PSMA-PET/CT with nuclear medicine specialist accuracy

S Moazemi, Z Khurshid, A Erle, S Lütje, M Essler… - Diagnostics, 2020 - mdpi.com
Gallium-68 prostate-specific membrane antigen positron emission tomography ( 68 Ga-PSMA-PET)
is a highly sensitive method to detect prostate cancer (PC) metastases. Visual …

[HTML][HTML] Estimating the potential of radiomics features and radiomics signature from pretherapeutic PSMA-PET-CT scans and clinical data for prediction of overall …

S Moazemi, A Erle, S Lütje, FC Gaertner, M Essler… - Diagnostics, 2021 - mdpi.com
Prostate-specific membrane antigen (PSMA) positron emission tomography/computed
tomography (PSMA-PET/CT) scans can facilitate diagnosis and treatment of prostate disease. …

PSMA ligands in prostate cancer–Probe optimization and theranostic applications

S Lütje, R Slavik, W Fendler, K Herrmann, M Eiber - Methods, 2017 - Elsevier
Due to its selective overexpression in prostate cancer (PCa), the prostate-specific membrane
antigen (PSMA) has been recognized as a highly promising target for diagnostic and …